Sarepta Stock Falls. Why It's Caving Into the FDA and What Comes Next.

• click to rate

  Posted by Two Blokes Jul 22 - Filed in Stock - 7 views
  
  The company agreed to voluntarily halt shipments of its experimental medicine Elevidys for Duchenne muscular dystrophy.